Deriphylline Restard 150 mg: Indications, Dosage, and Contraindications
Critical Error in Evidence Provided
The FDA drug label evidence provided 1 is for lamotrigine (an antiepileptic/mood stabilizer), NOT for Deriphylline/theophylline. This appears to be a database error. I will answer based on the guideline and research evidence for theophylline, which is the actual active ingredient in Deriphylline Restard.
Indications
Deriphylline Restard (sustained-release theophylline 150 mg) is indicated for chronic stable asthma and chronic bronchitis as maintenance bronchodilator therapy, but NOT for acute exacerbations.
Primary Indications:
- Chronic stable asthma as alternative (not preferred) maintenance therapy 2
- Chronic bronchitis with chronic cough - Grade A recommendation for stable patients 2
- COPD maintenance therapy in patients requiring step-up bronchodilation 3, 4
Key Clinical Context:
The guidelines are clear: theophylline should be considered for controlling chronic cough in stable chronic bronchitis patients, but careful monitoring for complications is necessary 2. However, for acute exacerbations of chronic bronchitis, theophylline should NOT be used (Grade D recommendation) 2.
For asthma, theophylline is listed as an alternative but not preferred therapy compared to inhaled corticosteroids 5, 6, 7. It may be used as add-on therapy in step 3-4 asthma management 8.
Dosage
For adults with chronic respiratory disease: Start with 400 mg/day (approximately 200 mg twice daily with sustained-release formulation), titrate gradually every 3 days based on tolerance, targeting serum theophylline levels of 5-12 mcg/mL.
Specific Dosing Algorithm:
Initial Dosing:
- Adults: 16 mg/kg/day or 400 mg/day (whichever is less), divided into 2 doses with sustained-release formulation 9
- Start LOW to minimize side effects 10, 11
Titration Strategy:
- Increase dose at 3-day intervals if tolerated and no side effects 12, 9
- Slow clinical titration decreases caffeine-like side effects from >50% to only 1-2% 10
Target Serum Levels:
- Therapeutic range: 5-12 mcg/mL for pregnancy 5
- Traditional range: 10-20 mcg/mL for general use 10, 13, 11
- Optimal range for chronic bronchitis: 5-15 mcg/L 3
Monitoring:
- Measure serum theophylline concentration to guide final dosage 10, 11, 14
- Recheck levels after 6-12 months or with clinical changes 12, 9
- Mandatory monitoring in elderly, hepatic disease, heart failure, and with interacting drugs 5, 14, 15
Age-Specific Considerations:
- Children 1-8 years: Mean clearance 0.092 L/kg/hr - require higher weight-adjusted doses 16
- Children >9 years: Clearance decreases progressively 12
- Elderly: Start with lower doses (400-600 mg/day) due to decreased clearance 15
Contraindications
Absolute Contraindications:
- Acute exacerbations of chronic bronchitis or COPD - Grade D recommendation 2
- Bradycardia-tachycardia syndrome (sick sinus syndrome) 15
- Frequent ventricular ectopy 15
- Known hypersensitivity to theophylline or xanthine derivatives
Relative Contraindications/Require Extreme Caution:
- Hepatic insufficiency - requires dose reduction and plasma monitoring 8, 14, 15
- Heart failure - alters theophylline clearance 14, 15
- Elderly patients - decreased clearance, higher toxicity risk 2, 15
- Pregnancy - use only if benefits outweigh risks; maintain levels 5-12 mcg/mL 5
Critical Drug Interactions
Theophylline has serious potential for drug-drug interactions 5:
- Erythromycin - significantly increases theophylline levels 5
- Ciprofloxacin - decreases clearance 15
- Smoking - increases clearance, requires higher doses 14, 15
- Carbamazepine, phenytoin - when used with theophylline for other conditions 14
Common Pitfalls to Avoid
- Never use for acute exacerbations - this is explicitly contraindicated 2
- Don't start with high doses - begin low and titrate slowly to avoid side effects 10, 9
- Don't forget serum monitoring - theophylline has narrow therapeutic index 10, 13, 11
- Watch for toxicity signs - nausea, vomiting, tachycardia, seizures at high levels 13
- Adjust for age and comorbidities - elderly and those with liver/heart disease need lower doses 14, 15